Evidence map›Paper›PMID 32103419›Full record

ArticleAnnals of surgical oncology2020

Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma.

Pim B Olthof, Luca Aldrighetti, Ruslan Alikhanov, Matteo Cescon, Bas Groot Koerkamp, William R Jarnagin, Silvio Nadalin, Johann Pratschke, Moritz Schmelze, Ernesto Sparrelid and 4 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Annals of surgical oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 42 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 3 pooled it
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 3 syntheses or guidelines pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. [Klatskin tumors-differentiated surgical treatment].Chirurgie (Heidelberg, Germany) · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. The Downside of Portal Vein Embolization: Is It Still Worth It?Cardiovascular and interventional radiology · 2024
    Article
  18. Article
  19. Article
  20. Practice guidelines for managing extrahepatic biliary tract cancers.Annals of hepato-biliary-pancreatic surgery · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 6 countries.

Pim B OlthofDepartment of Surgery, Amsterdam UMC (location AMC), University of Amsterdam, Amsterdam, The Netherlands. p.b.olthof@amc.nl.
Luca AldrighettiHepato-biliary Surgery Division, Ospedale San Raffaele-IRCCS, Milan, Italy.
Ruslan AlikhanovHepato-biliary Surgery Division, Ospedale San Raffaele-IRCCS, Milan, Italy.
Matteo CesconDepartment of Medical and Surgical Sciences, S. Orsola-Malpighi Hospital, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
Bas Groot KoerkampDepartment of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
William R JarnaginDivision of Hepatopancreatobiliary Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Silvio NadalinDepartment of General and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany.
Johann PratschkeDepartment of General, Visceral and Transplantation Surgery, Charité University Hospital, Berlin, Germany.
Moritz SchmelzeDepartment of General, Visceral and Transplantation Surgery, Charité University Hospital, Berlin, Germany.
Ernesto SparrelidDepartment of Surgery, Centre for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden.
Hauke LangDepartment of General, Visceral and Transplantation Surgery, University Hospital of Mainz, Mainz, Germany.
Alfredo GuglielmiDepartment of Surgery, Unit of Hepato-Pancreato-Biliary Surgery, University of Verona Medical School, Verona, Italy.
Thomas M van GulikDepartment of Surgery, Amsterdam UMC (location AMC), University of Amsterdam, Amsterdam, The Netherlands.
Perihilar Cholangiocarcinoma Collaboration Group
Charité - Universitätsmedizin Berlin · DEIRCCS Ospedale San Raffaele · ITUniversity of Amsterdam · NLErasmus MC · NLKarolinska University Hospital · SEMemorial Sloan Kettering Cancer Center · USUniversity Children's Hospital Tübingen · DEUniversity Medical Center of the Johannes Gutenberg University Mainz · DEUniversity of Bologna · ITUniversity of Verona · IT

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundPreoperative portal vein embolization (PVE) is frequently used to improve future liver remnant volume (FLRV) and to reduce the risk of liver failure after major liver resection.

objectiveThis paper aimed to assess postoperative outcomes after PVE and resection for suspected perihilar cholangiocarcinoma (PHC) in an international, multicentric cohort.

methodsPatients undergoing resection for suspected PHC across 20 centers worldwide, from the year 2000, were included. Liver failure, biliary leakage, and hemorrhage were classified according to the respective International Study Group of Liver Surgery criteria. Using propensity scoring, two equal cohorts were generated using matching parameters, i.e. age, sex, American Society of Anesthesiologists classification, jaundice, type of biliary drainage, baseline FLRV, resection type, and portal vein resection.

resultsA total of 1667 patients were treated for suspected PHC during the study period. In 298 patients who underwent preoperative PVE, the overall incidence of liver failure and 90-day mortality was 27% and 18%, respectively, as opposed to 14% and 12%, respectively, in patients without PVE (p < 0.001 and p = 0.005). After propensity score matching, 98 patients were enrolled in each cohort, resulting in similar baseline and operative characteristics. Liver failure was lower in the PVE group (8% vs. 36%, p < 0.001), as was biliary leakage (10% vs. 35%, p < 0.01), intra-abdominal abscesses (19% vs. 34%, p = 0.01), and 90-day mortality (7% vs. 18%, p = 0.03).

conclusionPVE before major liver resection for PHC is associated with a lower incidence of liver failure, biliary leakage, abscess formation, and mortality. These results demonstrate the importance of PVE as an integral component in the surgical treatment of PHC.

Indexed as

Bile Duct NeoplasmsEmbolization, TherapeuticKlatskin TumorLiver FailureLiver NeoplasmsPortal VeinAgedHepatectomyHumansMaleMiddle AgedPreoperative CareRetrospective Studies

Identifiers

PMID32103419
PMCPMC7311501
OpenAlexW3008827202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.